Given all the big $ biotech buyouts being announced, it is clearly time to strike while the iron is hot. A recession, a stock market collapse, an antibusiness congress after next election, any of these could tank the prices paid for biotechs. Sell now is the smart strategy.
News 
Market Data 
Discover 
AI
